Alambic Investment Management, L.P. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 194 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$310,000
-92.6%
18,355
-91.5%
0.08%
-85.5%
Q1 2018$4,210,000
+266.1%
214,887
+278.5%
0.59%
+324.6%
Q4 2017$1,150,000
+55.6%
56,773
+33.4%
0.14%
+70.4%
Q3 2017$739,000
+84.3%
42,573
+36.1%
0.08%
+65.3%
Q2 2017$401,000
+2.8%
31,273
+4.0%
0.05%
+2.1%
Q1 2017$390,000
+124.1%
30,073
+71.1%
0.05%
+54.8%
Q4 2016$174,000
-17.9%
17,5730.0%0.03%
-38.0%
Q3 2016$212,000
+29.3%
17,573
-7.4%
0.05%
+22.0%
Q2 2016$164,000
-65.0%
18,973
-61.7%
0.04%
-73.0%
Q1 2016$469,000
-23.5%
49,573
+40.0%
0.15%
-58.8%
Q4 2015$613,00035,4000.37%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders